
The acquisition brings Gallant’s experimental stem cell treatments for feline chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
Check out this week's highlights.
Friday is here again! To kick off the weekend, we're delivering our coverage of the latest veterinary news and hot topics directly to your fingertips.
Here are this week's highlights:
Stay tuned on social media and dvm360.com for more veterinary news.




